Angiography Catheters Market to Reach USD 2.4 Billion by 2031 | Rising Demand for Minimally Invasive Procedures Driving Growth

The global angiography catheters market, valued at USD 1.4 billion in 2022, is projected to grow at a CAGR of 6.3%, reaching USD 2.4 billion by 2031. Increasing demand for minimally invasive procedures, growing prevalence of cardiovascular diseases, and advancements in angiographic imaging technologies are key factors fueling market growth.

Get a concise overview of key insights from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85417

Market Overview

Angiography catheters are medical devices used in diagnostic and therapeutic procedures such as angiograms, angioplasty, and embolization. They allow healthcare providers to visualize blood vessels and diagnose conditions such as coronary artery disease, peripheral artery disease, and aneurysms. Growing demand for catheter-based interventions over traditional surgical procedures is significantly boosting market expansion.

Analysts' Viewpoint

The angiography catheters market is poised for steady growth due to:

Rise in cardiovascular diseases, which remain a leading cause of mortality worldwide

Increased adoption of minimally invasive procedures, offering lower risks and faster recovery times

Technological innovations in catheter-based imaging and diagnostic tools

Growing geriatric population prone to chronic diseases

However, risks associated with catheterization, such as infections and complications, along with high procedural costs could restrict market growth in some regions.

Market Drivers

Increasing Preference for Minimally Invasive Surgeries (MIS)

Minimally invasive procedures reduce recovery time, hospital stays, and procedural risks, making them the preferred option over traditional open surgeries.

Angiography catheters play a crucial role in procedures like angioplasty and stent placement, supporting the trend toward catheter-based interventions.

Advanced catheter technologies, such as drug-eluting and bioresorbable stents, are further improving the safety and efficacy of MIS.

Rising Global Prevalence of Cardiovascular Diseases (CVDs)

According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death worldwide.

The increase in cases of coronary artery disease, strokes, and peripheral artery disease is driving demand for advanced diagnostic tools like angiography catheters.

Aging populations and unhealthy lifestyles are contributing to the growing burden of cardiovascular diseases.

Advances in Angiographic Imaging & Catheter Technologies

New-generation catheters feature better flexibility, enhanced trackability, and reduced procedural complications.

Integration of AI and machine learning in angiographic imaging is improving diagnosis accuracy and procedural success rates.

Innovations such as robotic-assisted catheterization and bioresorbable polymer coatings are enhancing procedural efficiency.

Expansion of Healthcare Infrastructure & Government Initiatives

Governments worldwide are investing in healthcare infrastructure, particularly in emerging markets like India and China, leading to increased adoption of angiography procedures.

Favorable reimbursement policies in North America and Europe are further encouraging hospitals to invest in advanced catheter-based diagnostic tools.

Visit our report for a deep dive into key insights and conclusions -

https://www.transparencymarketresearch.com/angiography-catheters-market.html

Market Segmentation

By Procedure

Selective Angiography, Non-selective Angiography

By Application

Cardiology, Endovascular, Neurology, Oncology, Others

By End-user

Hospitals, Diagnostic & Imaging Centers, Others

Regional Outlook

North America (Leading Market, Holding 40% Market Share in 2022)

The U.S. dominates due to high cardiovascular disease prevalence, strong healthcare infrastructure, and rapid adoption of advanced catheter-based technologies.

FDA approvals and reimbursement support for minimally invasive procedures are boosting angiography catheter adoption.

Major players such as Abbott, Boston Scientific, and Medtronic have a strong presence in the region.

Europe (Significant Growth Due to Favorable Government Policies & R&D Investments)

European healthcare systems are supporting minimally invasive cardiac procedures through reimbursement programs.

Germany, France, and the U.K. are leading markets due to high adoption of catheter-based interventions.

Asia Pacific (Fastest-growing Market, Expected to Expand at 7.3% CAGR Through 2031)

Rapidly growing aging populations in China, Japan, and India are increasing the demand for angiographic procedures.

Governments are investing heavily in healthcare infrastructure and cardiovascular disease prevention programs.

Medical device manufacturers are expanding their presence in Asia Pacific due to the growing demand for advanced angiography systems.

Latin America & Middle East & Africa (Emerging Markets with Growth Potential)

Brazil and Mexico are witnessing increased adoption of catheter-based diagnostic procedures due to improving healthcare access.

GCC countries are investing in cardiovascular disease prevention and expanding catheterization labs in hospitals.

Competitive Landscape

The angiography catheters market is highly competitive, with key players focusing on technological advancements, new product launches, and strategic partnerships to enhance their market share.

Leading Companies:

Abbott

Boston Scientific Corporation

Medtronic

Braun SE
Cook Medical

Cordis Corporation

AngioDynamics

OSCOR, Inc.

BVM Medical Limited

Terumo Europe NV

iVascular

Teleflex Incorporated

Recent Developments:

May 2019: Cardinal Health launched the Cordis RADIAL 360 portfolio in the U.S., offering a complete range of tools for transradial access in interventional cardiology procedures.

2022: Abbott launched the Hi-Torque Supra Core Guidewire, designed for improved navigation and access during percutaneous coronary interventions (PCIs).

2021: Boston Scientific expanded its portfolio of catheter-based diagnostic solutions by acquiring Devoro Medical, a company specializing in thrombus removal technology.

Future Outlook

The angiography catheters market is set for steady expansion, driven by:

Rising global burden of cardiovascular diseases

Growing adoption of minimally invasive procedures

Technological innovations in catheter-based imaging and diagnostics

Expanding healthcare access in emerging economies

While cost constraints and regulatory hurdles may pose challenges, ongoing R&D efforts and increasing investments in healthcare infrastructure will sustain market growth. 🚀

Buy this Premium Research Report for strategic insights and recommendations -

https://www.transparencymarketresearch.com/checkout.php?rep_id=85417<ype=S

FAQs

Q1: What is the growth rate of the angiography catheters market?

A: The market is expected to grow at a CAGR of 6.3% from 2023 to 2031.

Q2: Which region dominates the market?

A: North America leads the market with a 40% share, followed by Europe and Asia Pacific.

Q3: What are the key factors driving market growth?

A: Increasing prevalence of cardiovascular diseases, growing preference for minimally invasive surgeries, and advancements in angiographic imaging technologies.

Q4: Which companies are leading the market?

A: Abbott, Boston Scientific, Medtronic, B. Braun, and Cook Medical are among the major players.

Increasing demand for minimally invasive cardiac procedures, technological advancements, and expanding healthcare access are driving market growth.
Explore Latest Research Reports by Transparency Market Research:

Biologics Market - https://www.transparencymarketresearch.com/global-biologics-market.html

Blood Gas and Electrolyte Analyzers Market - https://www.transparencymarketresearch.com/blood-gas-electrolyte-analyzers-market.html

Indwelling Catheters Market - https://www.transparencymarketresearch.com/indwelling-catheter-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.